Commentary

Dear Mr. Morgenthaler,

Thank you for the “Health & Wellness Update.” I look forward to each issue, and the solid information it provides.

Praise for
Smart Publications
Health & Wellness Update

"Wealth of information for anyone that chooses alternative healing methods. It's an education in itself just to read one of these newsletters! Every time I get one I read it from cover to cover! Easy to understand and easy to decipher when looking for products. Well done! It's a joy to read."

The Eggplant Cancer Cure

A Treatment for Skin Cancer and
New Hope for Other Cancers
From Natures Pharmacy

by Dr. Bill E. Cham, Ph.D.
$24.95 - 132 pages, hardcover

• Table of Contents
• Previous Chapter
• Next Section - Glossary
  

Bibliography

1. American Cancer Society. www.cancer.org
   
   
2. Canadian Centre for Occupational Health and Safety.
   www.ccohs.ca
   
   
3. E Health MD. http:/www.ehealthmd.com
   
   
4. Skincancer Foundation. www.skincancer.org
   
   
5. Cham, B. E. and Wilson, L. (1987). HPLC of glycoalkaloids from Solanum sodomaeum L. Planta Med. 53, 59-61.
   
   
6. Bajaj, K. L., Kaur, G. and Chada, M. L. (1979). Glycoalkaloid content and other chemical constituents of the fruits of some egg plant (Solanum melongena, L.) varieties. J. Plant Foods, 3, 163-168.
   
   
7. Chen, Z. and Miller, A. (2001). Steroidal Alkaloids in solanaceous vegetable crops. Horticul. Rev. 25. 171- 186.
   
   
8. Cipollini, M. L. (2000). Secondary metabolites of vertebrate – dispersed fruits; evidence for adaptive functions. Rev. Chil. Hist. Nat. 73. 421-440.
   
   
9. Ghazi, M. and Matthees, D. P. (1989). Use of ion-pairing reversed-phase liquid chromathography in separation of solanidine and solasodine. J. Chem. Exol. 15. 2661-2666.
   
   
10. Jones, P.G. and Fenwick, G.R. (1981). The glycoalkaloid content of some edible Solanaceous fruits and potato products. J. Sci, Food Agric. 32. 419-421.
    
    
11. Lequart, V., Goethals, G., Banoub, J., Villa, P. and Martin, P. (2004). An Improved Synthesis of Chacotriose. Chem. Let. 33. 444.
    
    
12. Morillo, M., Lequart, V., Grand, E., Goethals, G., Usubillaga, A., Villa, P. and Martin, P. (2001). Synthesis of peracetylated chaco-triose. Carbohyd. Res. 334, 281-287.
    
    
13. Nada, C., Nikolic, A., Mihajlo, Z., Stankovic, A. G., Dejan, Z. and Markovic, C. D. (2005). Liquid-liquid systems for acid hydrolysis of glycoalkaloids from Solanum tuberosum L. tuber sprouts and solanidine extraction. Med. Sci. Monit. 11(7). BR200-205.
    
    
14. Schreiber, K. (1968). Steroidal alkaloids: The Solanum group. In the alkaloids Vol 10, (Mansk, K., Ed.). Academic Press.
    
    
15. Cham, B. E. (1988). Monograph on the compound BEC. Drugs of the Future. 13, 714-716.
    
    
16. Daunter, B. and Cham, B. E. (1990). Solasodine glycosides. In vitro preferential cytotoxicity for human cancer cells. Cancer Letters 55, 209-220.
    
    
17. Cham, B. E. (1989). Curaderm (antineoplastic). Launched in Australia. Drug News and Perspectives 2, 112.
    
    
18. Cham, B. E. (1991). Solasodine glycosides: A new modality for cancer. In Proc. 2nd Oceania Symposium. Pp.30-36.
    Editor Mark S. Walker. Bioconcepts Publishing.
    
    
19. Cham, B. E. (1994). Solasodine glycosides as anti-cancer agents: Pre-clinical and clinical studies. Asia Pacif. J.
    Pharmacol. 9, 113-118.
    
    
20. Cham, B. E. (1993). Efficacy and mode of action of solasodine glycosides (BEC) on cancer cells. In Proc. 4th Oceania
    Symposium 0041-51. Editor Mark S. Walker. Bioconcepts Publishing.
    
    
21. Chataing, B., Christancho, N. B. and Usubillaga, A. (1998). Topical treatment of herpes simplex, herpes zoster and genital herpes with a mixture of Solanaceous glycoalkaloids. MedULA. Universidad de Los Andes. 7. 30-34.
    
    
22. Choi, E. and Koo, S. (2005). Anti-nociceptive and anti-inflam matory effects of the ethanolic extract of potato (Solanum
    tuberosum). Food Agri. Immun. 16. 29-39.
    
    
23. Hall, C. A., Hobby, T. and Cipollini, M. (2006). Efficacy and Mechanisms of α- Solasonine-and α-Solamargine-Induced Cytolysis on Two Strains of Trypanosoma cruzi. J.Chem. Ecol. 32. 2405-2416.
    
    
24. Kuo, K. W., Hsu, S. H., Li, Y. P., Lin, W. L., Liu, L. F., Chang, L. C., Lin, C. C., Lin, C. N. and Sheu, H. M. (2000). Anti cancer activity evaluation of the Solanum glycoalkaloid
    solamargine. Triggering apoptosis in human hepatoma cells. Biochem. Pharmacol. 60, 1865-1873.
    
    
25. Putalun, W., Taura, F., Qing, W., Matsushita, H., Tanaka, H and Shoyama, Y. (2003). Anti-solasodine glycoside single- chain Fv antibody stimulates biosynthesis of solasodine glycoside in plants. Plant Cell Rep. 22. 344-349.
    
    
26. Verpoorte, R. (1998). Exploration of nature’s chemodiversity: the role of secondary metabolites as leads in drug development. Drug Discov. Today 3, 232-238.
    
    
27. Vijayan, P., Vinod Kumar, S., Dhanaraj, S. A., Badami, S. and Suresh, B (2002). In Vitro Cytotoxicity and Anti-tumour Properties of the Total Alkaloid Fraction of Unripe Fruits of Solanum pseudocapsicum. Pharmaceut. Biol. 40. 456-460.
    
    
28. Cham, B. E., Gilliver, M. and Wilson, L. (1987). Antitumour effects of glycoalkaloids isolated from Solanum sodomaeum L. Planta Med. 53, 34-36.
    
    
29. Cham, B. E., Daunter, B. (1990). Solasodine glycosides. Selective cytoxicity for cancer cells and inhibition of
    cytotoxicity by rhamnose in mice with sarcoma 180. Cancer Letters, 55, 221-225.
    
    
30. Amalfi, C. (2006). The little mouse who wouldn’t say die. Cosmos Mag. 471.
    
    
31. Badami, S., Manohara Reddy, S.A., Kumar, E.P., Vijayan, P. and Suresh, B. (2003). Antitumour activity of total alkaloid fraction of Solanum pseudocapsicum leaves. Phytother. Res. 17. 1001-1004.
    
    
32. Chataing, B., Concepcion, J. L., Lobaton, R. and Usubillaga, A. (1998). Inhibition of Trypanosoma cruzi growth in vitro by Solanum alkaloids; a comparison with ketoconazole. Planta Med. 64, 31-36.
    
    
33. Chami, L.A., Méndez, R., Chataing, B., O’Callaghan, J., Usubillaga, A. and LaCruz, L. (2003). Toxicological effects of α-solamargine in experimental animals. Phyto Res. 17, 254- 258.
    
    
34. Chang, L. C., Tsai, T. R., Wang, J. J., Lin, C. N. and Kuo, K. W. (1998). The rhamnose moiety of solamargine plays a
    crucial role in triggering cell death by apoptosis. Biochem. Biophys. Res. Commun. 242, 21-25.
    
    
35. Esteves-Souza, A., Silva, T. M. and Alves, C. C. F. et al. (2002). Cytotoxic activities against Ehrlich carcinoma and human K562 leukaemia of alkaloids and flavonoid from two Solanum Species. J. Braz. Chem. Soc. 13. 838-842.
    
    
36. Hsu, S. H., Tsai, T. R., Lin, C. N., Yen, M. H. and Kuo, K. W. (1996). Solamargine purified from Solanum incanum
    Chinese herb triggers gene expression of human TNFR1 which may lead to cell apoptosis. Biochem. Biophys. Res. Commun. 229, 1-5.
    
    
37. Evans, R., Cham, B. E. and Daunter, B. (1989). Letter to the Editor. Your Pharmacy, January, 1.
    
    
38. Cham, B. E. and Meares, M. M. (1987). Glycoalkaloids from Solanum sodomaeum L. are effective in the treatment of skin cancers in man. Cancer Letters 36, 111-118.
    
    
39. Cham, B. E., Daunter, B and Evans, R. (1992). Topical
    treatment of malignant and premalignant skin cancers by very low concentration of a standard mixture of solasodine glycosides. Clinical Digest Series. Dermatology. 1992.
    
    
40. Cham, B. E., Daunter, B and Evans, R. (1991). Topical
    treatment of malignant and premalignant skin cancers by very low concentrations of a standard mixture of solasodine glycosides. Cancer Letters 59, 183-192.
    
    
41. Cham, B. E., Daunter, B and Evans, R. (1990). Curaderm. Med. J. Australia. 152, 329-330.
    
    
42. Cham, B. E., Daunter, B. (1990). Topical treatment of
    pre-malignant and malignant skin cancers with Curaderm. Drugs of Today 26, 55-58.
    
    
43. Cham, B. E. (1989). Plants yield skin cancer cure. Austral. Technol. Rev. 2, 53.
    
    
44. Millward, M., Powell, A., Daly, P., Tyson, S., Ferguson, R.
    and Carter, S. (2006). Results of phase I clinical trials of
    Coramsine in patients with advanced solid tumours.
    J. Clin. Oncol. 24, 2070.
    
    
45. Nakamura, T., Komori, C., Lee, Y., Hashinoto, F., Yahara, S., Nohara, T., and Ejina, A. (1996). Cytotoxic activities of
    Solanum steroidal glycosides. Biol. Biopharm. Bull. 19, 564- 566.
    
    
46. Roddick, J. G., Rÿrenber, A. L. and Weissenber, M. (1990). Membrane-disrupting properties of the steroidal glycoalkaloids Solasonine and Solamargine. Phyto. Chem. 29. 1513-1518.
    
    
47. Roddick, J. G., Weissenberg, M. and Leonard, A. L. (2001). Membrane disruption and enzyme inhibition by naturally – occurring and modified chaco-triose – containing Solanum steroidal glycoalkaloids. Phyto. Chem. 56, 603-610.
    
    
48. Jellinek, N. and Maloney, M. (2005). Escharotic and other botanical agents for the treatment of skin cancer: A review. J. Amer. Aca. Dermatol. 53. 486-495.
    
    
49. Moss, R. W. (1998). Herbs against cancer History and
    controversy. Equinax press, Inc. Brooklyn, N.Y.
    
    
50. Punjabi, S., Cook, I., Kersey, P., Marks, R., Finlay, A., Sharpe, G. et al. (2000). A double blind, multi-centre parallel group study of BEC-5 cream in basal cell carcinoma. Eur. Acad.
    Dermatol. Venereol. 14 (Suppl). 47-60.
    
    
51. Walsh, N. (2000). Promising Topical Therapy for Actinic
    Keratoses – Brief Article Dr S Punjabi. Uni. Liverpool.
    Family Pratice News. December 1 article.
    
    
52. Williams, D. G. (1995). The skin cancer cure nobody wants you to know about. Alternatives, 6, 17-22. Mountain Home Publishing.
    
    
53. Williams, D. G. (1995). The skin cancer cure so effective, it’s being kept secret. Ingram, TX: Mountain Home Publishing.
    
    
54. Dr Calméz Ltd. www.curaderm.net
    
    
55. Sussman, L.A.E. and Liggins, D.F. (1996). Incompletely
    excised basal cell carcinoma: a management dilemma? Aust. NZ. J. Surg. 66, 276-278.
    
    
56. Cham, B.E. (2007). Solasodine rhamnosyl glycosides in a cream formulation is effective for treating large and trouble some skin cancers. Res. J. Biol. Sci. 2(7) 749-761.
    
    
57. Caramelli, B., dos Santos Filho, R. D., Sposito Ade, C. and Martinez, T. L. (1998). Effect of eggplant on plasma lipid
    levels, lipidic peroxidation and the reversion of endothelial dysfunction in experimental hypercholesterolemia. Arq. Bras. Cardiol. 71(1). 89.
    
    
58. Guimaraes, P. R., Galvao, A.M., Batista, C. M., Azevedo, G. S., Oliveira, R. D., Lamounier, R. P., Freire, N., Barros, A. M., Sakurai, E., Oliveira, J. P., Vieira, E. C. and Alvarez- Leite, J. I. (2000). Eggplant (Solanum melongena) infusion has a modest and transitory effect on hypercholesterolemic subjects. Braz. J. Med. Biol. Res. 33(9). 1027-1036.
    
    
59. Marchiori Praça, J., Thomaz, A. and Caramelli, B. (2004). Eggplant (Solanum melongena) extract does not alter serum lipid levels. Arq. Bras. Cardiol. 82.(3). 269-272.
    
    
60. Ono, M., Nishimura, K., Suzuki, K., Fukushima, T., Igoshi, K., Yoshimitsu, H., Ikeda, T. and Nohara, T. (2006). Steroidal glycosides from the underground parts of Solanum
    sodomaeum. Chem. Pharm. Bull. 54, 230-233.
    
    
61. Cham, B.E. (2007). Solasodine rhamnosyl glycosides
    specifically bind cancer cell receptors and induce apoptosis and necrosis. Treatment for skin cancer and hope for internal
    cancers. Res. J. Biol. Sci. 2(4) 503-514.